Heppt, M. V., & Utikal, J. (2017). Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition. European journal of cancer, 82, . https://doi.org/10.1016/j.ejca.2017.05.038
Chicago-Zitierstil (17. Ausg.)Heppt, Markus V., und Jochen Utikal. "Prognostic Factors and Outcomes in Metastatic Uveal Melanoma Treated with Programmed Cell Death-1 or Combined PD-1/cytotoxic T-lymphocyte Antigen-4 Inhibition." European Journal of Cancer 82 (2017). https://doi.org/10.1016/j.ejca.2017.05.038.
MLA-Zitierstil (9. Ausg.)Heppt, Markus V., und Jochen Utikal. "Prognostic Factors and Outcomes in Metastatic Uveal Melanoma Treated with Programmed Cell Death-1 or Combined PD-1/cytotoxic T-lymphocyte Antigen-4 Inhibition." European Journal of Cancer, vol. 82, 2017, https://doi.org/10.1016/j.ejca.2017.05.038.